Article Information
History
- July 25, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- George Sakoulas, MD1,2,3,*,
- Matthew Geriak, PharmD1,
- Ravina Kullar, PharmD4,
- Kristina L. Greenwood, PhD, PhD5,
- MacKenzie Habib, BS5,
- Anuja Vyas, MD1,2,
- Mitra Ghafourian, MD1,
- Venkata Naga Kiran Dintyala, MD1 and
- Fadi Haddad, MD6
- 1Sharp Memorial Hospital, 7910 Frost Street, San Diego, CA 92123
- 2Sharp Rees-Stealy Medical Group, 300 Fir Street, San Diego, CA 92101
- 3Collaborative to Halt Antibiotic-Resistant Microbes (CHARM), Department of Pediatrics, University of California San Diego School of Medicine, 9500 Gilman Drive, La Jolla, CA 92093
- 4Expert Stewardship, Inc, 201 Ocean Avenue, Santa Monica, CA 90402
- 5Sharp Center for Research, 8695 Spectrum Center Blvd, San Diego, CA 92123
- 6Sharp Grossmont Hospital, 5555 Grossmont Center Dr, La Mesa, CA 91942
- ↵*Corresponding author: George Sakoulas, MD, UCSD School of Medicine Biomedical Research Facility II, Room 4114, 9500 Gilman Drive, Mail Code 0760, La Jolla, CA 92093-0760;; Phone: (858) 534-2325;; FAX: (858) 246-1868;; Email: gsakoulas{at}health.ucsd.edu
Posted July 25, 2020.
Intravenous Immunoglobulin (IVIG) Significantly Reduces Respiratory Morbidity in COVID-19 Pneumonia: A Prospective Randomized Trial
